Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort-Reference-Cited by-同舟云学术

Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohort

Published:2022-09-07 Issue:6 Volume:16 Page:1297-1307
ISSN:1936-0533
Container-title:Hepatology International
language:en
Short-container-title:Hepatol Int

Author:

Hsu Yao-Chun,Jun Dae Won,Peng Cheng-Yuan,Yeh Ming-Lun,Trinh Huy,Wong Grace Lai-Hung,Kim Sung Eun,Chen Chien-Hung,Oh Hyunwoo,Lin Chia-Hsin,Trinh Lindsey,Wong Vincent Wai-Sun,Yoon Eilleen,Ahn Sang Bong,Huang Daniel,Cho Yong Kyun,Jeong Jae Yoon,Jeong Soung Won,Kim Hyoung Su,Xie Qing,Liu Li,Riveiro-Barciela Mar,Tsai Pei-Chien,Accarino Elena Vargas,Toyoda Hidenori,Enomoto Masaru,Preda Carmen,Marciano Sebastián,Hoang Joseph,Huang Chung-Feng,Kozuka Ritsuzo,Yasuda Satoshi,Istratescu Doina,Lee Dong-Hyun,Su Jia-Ying,Huang Yen-Tsung,Huang Jee Fu,Dai Chia-Yen,Chuang Wan-Long,Yuen Man-Fung,Gadano Adrian,Cheung Ramsey,Lim Seng Gee,Buti Maria,Yu Ming-Lung,Nguyen Mindie H.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Hepatology

Link

https://link.springer.com/content/pdf/10.1007/s12072-022-10411-x.pdf

Reference34 articles.

1. Schweitzer A, Horn J, Mikolajczyk RT, et al. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546–1555

2. Polaris OC. Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study. Lancet Gastroenterol Hepatol. 2018;3:383–403

3. Huang YT, Jen CL, Yang HI, et al. Lifetime risk and sex difference of hepatocellular carcinoma among patients with chronic hepatitis B and C. J Clin Oncol. 2011;29:3643–3650

4. Lok AS, McMahon BJ, Brown RS Jr, et al. Antiviral therapy for chronic hepatitis B viral infection in adults: a systematic review and meta-analysis. Hepatology. 2016;63:284–306

5. Zoulim F, Poynard T, Degos F, et al. A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine. J Viral Hepat. 2006;13:278–288

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic effectiveness analysis of tenofovir alafenamide and tenofovir disoproxil fumarate on the treatment for chronic hepatitis B;Medicine;2024-05-17

2. Hepatocellular carcinoma surveillance after HBsAg seroclearance;Exploration of Digestive Diseases;2024-05-11

3. Long-Term HBsAg Titer Kinetics with Entecavir/Tenofovir: Implications for Predicting Functional Cure and Low Levels;Diagnostics;2024-02-25

4. The co-existence of NAFLD and CHB is associated with suboptimal viral and biochemical response to CHB antiviral therapy: a systematic review and meta-analysis;Frontiers in Gastroenterology;2024-01-24

5. Long-Term Hepatitis B Surface Antigen Profile and Seroclearance Following Antiviral Treatment: A Single-Center, Real-World Cohort Study;Biomedicines;2023-11-03